Spermidine
Spermidine is a polyamine that triggers autophagy via EP300 inhibition, with a 20-year Bruneck cohort signal (Kiechl 2018, n=829) showing 40% lower all-cause mortality in the top dietary tertile (HR 0.60). All published human efficacy data uses wheat germ extract, not synthetic trihydrochloride.
Spermidine scored 7.0 / 10 (💪 Strong recommend) on the BioHarmony scale as a Substance → Vitamin / Mineral / Nutrient.
What It Is
Spermidine is a polyamine your cells make and your gut microbiome produces, found in every food and every tissue. It triggers autophagy (cellular self-cleaning) by inhibiting EP300 acetyltransferase, and it powers hypusination of eIF5A, a translation factor required for mitophagy proteins like PINK1 and ATG3. Endogenous levels decline with age, and dietary intake is one of the only nutritional variables with a 20-year human mortality signal.
Type: Polyamine (natural wheat germ extract or synthetic trihydrochloride supplement).
Current status: WGE is EU Novel Food approved at 6 mg/day, sold by spermidineLIFE, Primeadine, and Nuchido TIME+. Synthetic 3HCL is sold widely in the US (Double Wood, Renue By Science, and the Bryan Johnson Blueprint stack) but has no published human outcome RCTs and was rejected by the FDA as a New Dietary Ingredient.
Terminology
- WGE: wheat germ extract, the natural whole-food source of spermidine used in every published human RCT.
- 3HCL: spermidine trihydrochloride, the synthetic salt form sold widely in the US with no human outcome data.
- EP300: an acetyltransferase enzyme that spermidine inhibits to trigger autophagy.
- eIF5A: eukaryotic translation initiation factor 5A, the only human protein that requires hypusination for function.
- Hypusination: a post-translational modification unique to eIF5A, required to translate mitophagy proteins like PINK1 and ATG3.
- PINK1: PTEN-induced kinase 1, a mitochondrial quality-control kinase that marks damaged mitochondria for mitophagy.
- ATG3: autophagy-related 3, a protein required for autophagosome formation.
- Autophagy: cellular self-cleaning; the process by which cells degrade and recycle damaged organelles and misfolded proteins.
- Mitophagy: selective autophagy of mitochondria.
- DFMO: difluoromethylornithine, an ornithine decarboxylase inhibitor used in neuroblastoma and chemoprevention protocols to starve tumors of polyamines.
- HR: hazard ratio; a statistic measuring relative risk over time in prospective cohort studies.
- NOAEL: no observed adverse effect level; the highest dose showing no toxicity in safety studies.
- Bruneck cohort: a prospective Italian population study (n=829) that tracked diet and mortality for 20 years.
- SmartAge: a 12-month RCT (Schwarz 2022, n=100) that tested 0.9 mg/day WGE on cognition in subjective cognitive decline.
Dosing & Protocols
Dosing information is summarized from published research and community reports. This is not a prescribing guide. Consult a healthcare provider before starting any protocol.
View 3 routes and 6 protocols
Routes & Forms
| Route | Form | Clinical Range | Community Range |
|---|---|---|---|
| Oral (WGE) | 1-3 mg/day wheat germ extract | 1-6 mg/day | |
| Oral (Synthetic 3HCL) | 5-15 mg/day synthetic 3HCL | ||
| Food / Whole Foods | 5-10 mg/day from dietary sources |
Protocols
WGE low-dose maintenance Clinical
- Dose
- 1-3 mg/day oral
- Frequency
- daily
- Duration
- indefinite
Single capsule with breakfast. Matches Primeadine and spermidineLIFE dosing.
WGE EU-capped dose Clinical
- Dose
- 3-6 mg/day oral
- Frequency
- daily
- Duration
- indefinite
EU 2017/2470 ceiling. Pregnant/lactating excluded.
Synthetic 3HCL aggressive Anecdotal
- Dose
- 10 mg/day oral
- Frequency
- daily
- Duration
- indefinite
Blueprint protocol. Accept uncontrolled self-experiment. Brands: Double Wood, Renue By Science.
Food-first approach Anecdotal
- Dose
- ~5-10 mg/day from whole foods
- Frequency
- daily
- Duration
- lifestyle
Cheapest, highest food-synergy, hardest to sustain.
Spermidine + resveratrol stack Mixed
- Dose
- 2-3 mg spermidine + 250-500 mg resveratrol daily
- Frequency
- daily
- Duration
- indefinite
Kroemer canonical pairing. Complementary EP300 inhibition + SIRT1 activation.
Spermidine + rapamycin synergy Mixed
- Dose
- 2-3 mg spermidine daily + rapamycin per protocol
- Frequency
- daily spermidine, weekly rapamycin
- Duration
- indefinite
Hofer 2024: endogenous spermidine required for rapamycin's autophagy effect. Synergistic, not redundant.
How this score is calculated →
Upside (1.88 / 5.00)
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Efficacy | 25% | 2.8 | 0.700 | |
| Breadth of Benefits | 15% | 4.0 | 0.600 | |
| Evidence Quality | 25% | 2.8 | 0.700 | |
| Speed of Onset | 10% | 1.5 | 0.150 | |
| Durability | 10% | 2.0 | 0.200 | |
| Bioindividuality Upside | 15% | 3.5 | 0.525 | |
| Total | 2.875 |
Upside Rationale
Efficacy (2.8/5.0): Kiechl 2018 Bruneck cohort (n=829, 20-year follow-up, AJCN) showed the top dietary tertile had all-cause mortality HR 0.60 (95% CI 0.44-0.82) versus bottom tertile, a magnitude similar to smoking cessation. Eisenberg 2016 (Nature Medicine) demonstrated aged-mouse left-ventricular diastolic dysfunction reversal via autophagy and mitophagy; Atg5-KO mice got zero benefit, the cleanest on-target confirmation in the literature. Rinaldi 2017 (n=100) found WGE cut telogen hair follicle count by 31% versus 13% placebo at 90 days (p<0.05). But Schwarz 2022 SmartAge (12-month RCT, n=100, 0.9 mg/day) missed its primary cognition endpoint in subjective-cognitive-decline patients; the dose was likely sub-therapeutic. Cohen's d is approximately 0.3 where measurable: meaningful benefit with caveats, not transformative.
Breadth (4.0/5.0): Polyamines sit upstream of autophagy, mitophagy, protein translation, and T-cell function per Madeo 2018 (Science). Documented signals span cardiovascular aging (Eisenberg 2016 aged-mouse LV diastolic reversal; Kiechl 2018 human mortality HR 0.60), hair-follicle cycling (Rinaldi 2017 telogen -31%), cognitive trends (Schwarz 2022 verbal memory p=0.07), immune rejuvenation (Alsaleh 2020 T-cell autophagy restoration), epigenetic reprogramming (Madeo lab TruDiagnostic signal in pilot data), liver autophagy and HCC prevention (Yue 2017 Cancer Research mouse model), and ocular autophagy plausibility for AMD. That's seven distinct organ systems affected by a single upstream mechanism (EP300 inhibition plus eIF5A hypusination), which is why spermidine scores higher on breadth than most targeted supplements. Compare against creatine (primarily muscle + cognition) or urolithin A (primarily mitochondrial). Spermidine's mechanism is systemic because autophagy is systemic.
Evidence (2.8/5.0): Tier 4 observational (Kiechl Bruneck n=829, Soda 2009 Japan polyamine epidemiology) plus tier 3 single-RCT (Schwarz SmartAge, Rinaldi hair) plus tier 5 traditional use (polyamine-rich fermented foods across cultures for millennia) plus tier 7 mechanistic (Eisenberg, Madeo, Kroemer lab). Compounds well, but the primary SmartAge RCT was null, which is why evidence sits at 2.8 not higher. No Cochrane review exists yet.
Speed (1.5/5.0): Rinaldi 2017 hair-cycle RCT detected statistically significant telogen reduction only at the 90-day measurement point, not earlier. Schwarz 2022 SmartAge showed no cognitive signal until the 12-month primary endpoint, and that endpoint was still null. Eisenberg 2016 aged-mouse cardiac reversal required 6 weeks of continuous supplementation before diastolic function measurably improved. The Bruneck mortality benefit requires 20 years of dietary exposure to materialize. No published human trial has ever detected a sub-30-day efficacy signal. Spermidine is a slow, cumulative autophagy-induction intervention: there is no same-day felt effect, no same-week biomarker shift, no first-month subjective change. You supplement for the long arc or not at all. If you expect to feel spermidine like caffeine, methylene blue, or a stimulant peptide, you will be disappointed and stop taking it before any benefit accrues.
Durability (2.0/5.0): No human RCT has measured spermidine washout longitudinally, per Madeo 2018 Science review of the field. The best inference is from polyamine pharmacokinetics (Pegg 2016): plasma half-life 18-24 hours, so supplemental spermidine clears within 2-3 days of stopping. Cellular autophagy tone induced by EP300 inhibition presumably normalizes over similar timescales, returning to whatever your dietary polyamine intake supports. The Bruneck cohort's 20-year mortality benefit reflects sustained high-polyamine-intake phenotypes, not one-time dosing legacy effects. Eisenberg 2016 mouse data showed the cardioprotective benefits faded within weeks of discontinuation. Treat spermidine as a daily-take intervention, not a cycled or pulsed protocol that banks benefits. Unlike creatine (where saturation persists weeks after stopping) or methylene blue (where mitochondrial adaptations appear to carry), spermidine gives you back exactly what you put in, and nothing more.
Bioindividuality (3.5/5.0): Age-related spermidine decline is universal per the Madeo 2018 framework. People with low dietary polyamine intake (low-wheat, low-aged-cheese, low-natto diets) should respond most. People already eating 10+ mg/day from food may see diminishing returns. Nick's TruDiagnostic TruHealth panel flagged him as deficient despite a nutrient-dense diet, which suggests even well-fed eaters can run low. Pregnant or lactating women are excluded per EU Novel Food 2017/2470. Active cancer patients are a hard contraindication.
Downside (0.53 / 5.00)
| Dimension | Weight | Score | Visual | Weighted |
|---|---|---|---|---|
| Safety Risk | 30% | 1.8 | 0.540 | |
| Side Effect Profile | 15% | 1.3 | 0.195 | |
| Financial Cost | 5% | 2.5 | 0.125 | |
| Time/Effort Burden | 5% | 1.2 | 0.060 | |
| Opportunity Cost | 5% | 1.3 | 0.065 | |
| Dependency / Withdrawal | 15% | 1.0 | 0.150 | |
| Reversibility | 25% | 1.1 | 0.275 | |
| Total | 1.410 | |||
| Harm subtotal × 1.4 | 1.624 | |||
| Opportunity subtotal × 1.0 | 0.250 | |||
| Combined downside | 1.874 | |||
| Baseline offset (constant) | −1.340 | |||
| Effective downside penalty | 0.534 |
Downside Rationale
Safety (1.8/5.0): WGE has FDA GRAS status as a food ingredient, EU Novel Food authorization (2017/2470) with a 6 mg/day adult cap, and no FAERS signals through Q4 2025. No deaths, organ failure, or anaphylaxis at normal doses. The principled risks: wheat/gluten cross-reactivity for celiac patients (most WGE brands don't claim gluten-free), and the polyamine-cancer paradox. Dietary polyamines are protective in healthy adults (Bruneck HR 0.76 per tertile increment), but exogenous polyamines may accelerate already-established polyamine-dependent tumors per Holbert 2023 T-cell suppression data. Lifelong mouse administration does not increase cancer incidence. This is a hard contraindication for active cancer, not a red flag for healthy users.
Side effects (1.3/5.0): Schwarz 2022 SmartAge (12-month RCT, n=100, 0.9 mg/day WGE) reported zero adverse events above placebo across primary and secondary safety endpoints: no laboratory abnormalities, no vital sign changes, no new symptom clusters. Rinaldi 2017 (n=100, 2 mg/day WGE, 90 days) similarly reported no treatment-emergent adverse events. The only signal consistent across community-aggregated reports (Reddit r/longevity, Examine, Longecity) is mild GI upset (bloating, transient nausea) at doses above 5 mg/day or when taken on an empty stomach, self-resolving within days of dose adjustment. No hormonal cascades, no sleep disruption, no mood effects, no cognitive fog, no hepatotoxicity signals across any published trial. This is among the cleanest side-effect profiles in the longevity supplement class, comparable to creatine monohydrate or glycine.
Cost (2.5/5.0): Branded WGE products sit at $60-90/month (spermidineLIFE $75/mo at 1 mg/day, Primeadine $85/mo at 1-2 mg/day with full polyamine profile, Nuchido TIME+ $99/mo bundled). Synthetic 3HCL is significantly cheaper at $15-30/month (Double Wood 10 mg/day runs $20/mo, Renue By Science liposomal $28/mo). Food-first is cheapest: roughly $10/month for a 500g bag of fresh wheat germ that lasts 40 days at 3 tablespoons/day. EU telehealth channels and Amazon EU shipping to North America reduce WGE premium by 20-40%. Per v0.5 cost rule, the score reflects the most accessible legitimate channel a motivated user would reasonably choose, not the luxury concierge-brand retail price. For the studied (WGE) form, expect to pay $40-90/month; the lower end if you import from EU or pair with food sources.
Effort (1.2/5.0): One oral capsule per day with or without food, per all published clinical protocols (Schwarz 2022 SmartAge 0.9 mg/day, Rinaldi 2017 WGE 2 mg/day). Under 10 seconds of daily friction. No timing stacks, no cycling window to track, no cold-chain storage, no loading protocol, no titration, no bloodwork monitoring required for safety. The food-first approach (3-4 tablespoons fresh wheat germ over yogurt or oatmeal, or a daily serving of natto) adds 2-3 minutes of prep but carries nutrient-density upside that isolated supplementation can't match. Spermidine is one of the lowest-friction longevity interventions available. Compare against rapamycin (weekly dose, bloodwork monitoring, prescription coordination) or NAD+ IV infusions (90-minute sessions, clinic visits, cost) to see how little operational overhead this requires.
Opportunity cost (1.3/5.0): Stacks cleanly with every longevity intervention Nick cares about: resveratrol (Kroemer canonical pairing, complementary acetyltransferase inhibition + SIRT1), rapamycin (Hofer 2024 showed endogenous spermidine is required for rapamycin's autophagy effect, meaning they are synergistic rather than redundant), urolithin A, NMN, and NR. The one hard antagonism is DFMO.
Dependency (1.0/5.0): Zero adaptation or dependency signal in any published human or animal trial, per Madeo 2018 Science comprehensive review. Spermidine is a dietary polyamine present in nearly every whole food you eat, so supplementation sits on top of substantial baseline exposure. There is no receptor system to downregulate, no reward circuit to hijack, no hormonal axis to suppress. Schwarz 2022 SmartAge 12-month data showed no withdrawal symptoms, no rebound cognitive decline, and no behavioral changes upon discontinuation. This is purely functional supplementation: you take it for the autophagy tone it induces while on it, and cellular processes return to dietary-intake baseline when you stop. No tolerance escalation has ever been documented. Contrast this with caffeine (receptor downregulation), benzodiazepines (addiction-tier), or even melatonin (suppresses endogenous production at high doses) to see why spermidine gets a 1.0 floor score on this dimension.
Reversibility (1.1/5.0): Full reversibility within days of discontinuation. Plasma polyamine half-life is approximately 18-24 hours (Pegg 2016 review on polyamine metabolism), so exogenous spermidine clears systemic circulation rapidly once intake stops, returning cellular autophagy tone to dietary-baseline levels within 3-7 days. No irreversible physiological changes have ever been documented across 15+ years of human observational, interventional, and post-market safety data. No tissue remodeling, no epigenetic lock-in, no permanent receptor changes, no structural organ changes. The Bruneck mortality signal requires sustained decades-long dietary exposure, which means the benefit itself fades with discontinuation, same as most longevity interventions (NMN, NR, metformin, rapamycin). This is as clean a reversibility profile as any compound can have short of inert placebo, and significantly cleaner than anti-aging compounds that commit you to long-term tissue-level adaptations (HRT, testosterone, anabolic-stack peptides).
Verdict
✅ Best for: Healthy adults over 40 who want a low-effort, food-based autophagy lever with the longest human mortality signal of any modern longevity compound. People whose TruDiagnostic, Function Health, or similar panels flag polyamine deficiency. Cardiovascular-risk populations not on active antitumor therapy. Post-menopausal women concerned about hair density (Rinaldi data). Stackers pairing it with resveratrol and/or rapamycin.
❌ Avoid if: Active cancer, particularly polyamine-dependent tumors like neuroblastoma or aggressive prostate. Pregnancy, lactation, or DFMO chemoprevention protocol (absolute contraindications). Diagnosed celiac without a gluten-tested WGE source. Also skip if you demand Phase 3 RCT efficacy in your primary endpoint before supplementing, because the Bruneck signal is observational and SmartAge was null.
⚠️ Supply chain note: Synthetic 3HCL from Chinese bulk supply lacks contamination audit (Dorado 2025 recall). Choose WGE from EU-regulated brands for the safety margin unless you explicitly accept the extrapolation risk.
Use Case Breakdown
The overall BioHarmony score reflects the intervention's primary evidence profile. These subratings are independent assessments per use case.
| Use Case | Score | Summary |
|---|---|---|
| ✅ Autophagy | 8.0 | Best-characterized dietary autophagy trigger (EP300 inhibition + hypusination). |
| 💪 Cardiovascular | 7.8 | Eisenberg 2016 aged-mouse LV diastolic reversal plus Kiechl 2018 Bruneck human mortality signal. |
| 💪 Longevity / Lifespan | 7.5 | Strongest human signal of any longevity supplement (Bruneck HR 0.60 top vs bottom tertile). |
| 💪 Geriatric / Aging Population | 7.2 | Highest-benefit population per Bruneck and SmartAge demographics. |
| 💪 Healthspan | 7.0 | Broad autophagy benefits plausibly extend healthspan; Bruneck morbidity signal. |
| 👍 Hair / Nail Health | 6.8 | Rinaldi 2017 RCT: telogen -31% vs -13% placebo at 90 days. |
| 👍 Mitochondrial | 6.5 | PINK1/ATG3 hypusination-dependent translation drives mitophagy. |
| 👍 Cellular Senescence | 6.5 | Autophagy clears senescent-associated damage; mechanistic and animal data. |
| 👍 Immune Function | 6.2 | T-cell function signals plus Madeo lab COVID observational data. |
| ⚖️ Skin / Beauty | 5.5 | Mechanistic autophagy story; limited human skin-aging RCTs. |
| ⚖️ Liver / Detoxification | 5.2 | Mouse autophagy data for NAFLD; no human RCTs. |
| ⚖️ Anti-Inflammatory | 5.0 | Indirect via autophagy and T-cell rejuvenation. |
| ⚖️ Stem Cell Support | 4.8 | Autophagy supports stem-cell maintenance; mouse data. |
| ○ Cognition / Focus | 4.5 | SmartAge 2022 null primary endpoint; verbal memory trend p=0.07; likely under-dosed. |
| ○ Neuroprotection | 4.5 | Mechanistic plausibility for Parkinson's and Alzheimer's; no human outcomes. |
| ○ Telomere / DNA Repair | 4.5 | Weak telomere signal; not primary mechanism. |
| ○ Metabolic Health | 4.2 | Weak observational signal; not a primary use case. |
| ○ Memory | 4.2 | SmartAge memory subscale trend but not statistically significant. |
| ○ Recovery / Repair | 4.0 | Autophagy supports cellular recovery; indirect. |
| ○ Antioxidant / Oxidative Stress | 4.0 | Indirect antioxidant role via mitophagy and cellular cleanup. |
| ○ Neuroplasticity | 3.8 | Plausible via autophagy; no clean human evidence. |
| ○ Fertility (Male) | 3.8 | Animal sperm-quality signal; no human RCT. |
| ○ Gut Health / Microbiome | 3.5 | Mechanistic gut microbiome polyamine production link; no human RCTs. |
| ○ Kidney Function | 3.5 | No positive or negative signal in humans. |
| ○ Eye / Vision Health | 3.5 | Autophagy plausible for AMD; no human outcome data. |
| ○ Endurance / Cardio | 3.5 | Cardiovascular autophagy plausible; no exercise RCTs. |
| ○ Methylation Support | 3.5 | Polyamine-methionine cycle crosstalk; no human outcome data. |
| ○ Wound Healing | 3.5 | Animal wound-healing data; no human RCTs. |
| ○ Energy / Fatigue | 3.5 | Indirect via mitochondrial quality control; no subjective-energy RCT. |
| ○ Nerve Regeneration | 3.0 | Animal nerve-injury models only. |
| ○ Injury Recovery | 3.0 | Plausible via autophagy; no RCTs in injury context. |
| ○ Traumatic Brain Injury | 3.0 | Mechanistic plausibility via autophagy; no TBI RCTs. |
Frequently Asked Questions
What does spermidine actually do in the body?
Spermidine triggers autophagy (cellular self-cleaning) by inhibiting the EP300 acetyltransferase, per Pietrocola 2015 in Cell Death & Differentiation. It also powers hypusination of the eIF5A translation factor, which is required to translate mitophagy proteins like PINK1 and ATG3. Eisenberg 2016 (Nature Medicine) confirmed on-target mechanism by showing aged-mouse cardiac reversal in wild-type animals and zero benefit in Atg5 autophagy-knockout mice.
How much spermidine should I take and in what form?
Clinical dosing uses 1-3 mg/day of wheat germ extract (WGE), per Schwarz 2022 SmartAge (0.9 mg) and Rinaldi 2017 hair RCT (2 mg). EU Novel Food sets a 6 mg/day adult ceiling. Synthetic 3HCL is commonly dosed 10 mg/day in the Bryan Johnson Blueprint, but no human outcome RCTs validate this form. Food sources delivering ~2-3 mg/day: 3-4 tablespoons fresh wheat germ, natto, aged cheeses, shiitake mushrooms.
Is the evidence for spermidine actually strong?
Evidence sits at moderate strength: Kiechl 2018 (Bruneck cohort, n=829) showed 20-year all-cause mortality HR 0.60 in the top dietary tertile, the largest human longevity signal of any modern supplement. However, the SmartAge 12-month RCT (Schwarz 2022, n=100, 0.9 mg/day) missed its primary cognition endpoint. Mechanistic work (Eisenberg 2016 Nature Medicine) is rigorous. No Cochrane review exists yet. The honest read: strong observational plus strong mechanism plus one null and one positive small RCT.
Natural wheat germ extract vs synthetic spermidine 3HCL: does the form matter?
Every published human trial used wheat germ extract (WGE), not synthetic spermidine trihydrochloride (3HCL). The 7.0/10 score applies to WGE; synthetic 3HCL scores ~5.8/10 because it has zero human outcome data, despite dominating the US market (Double Wood, Renue By Science, Blueprint). The FDA rejected synthetic 3HCL as a New Dietary Ingredient. Same molecule at a cellular level, but the evidence base differs completely. Choose WGE if you want the studied compound.
Is spermidine safe long-term?
Safety profile is clean at normal doses: FDA GRAS as a food ingredient, EU Novel Food authorization through 2025, no FAERS signals, no deaths, no organ failure, no anaphylaxis. The SmartAge 12-month RCT (Schwarz 2022) reported no safety signal above placebo. Mild GI complaints (bloating, nausea) occur in a small minority at high doses. Spermidine is a polyamine present in every food you eat, so supplementation sits on top of substantial dietary baseline exposure.
Who should NOT take spermidine?
Four hard contraindications: (1) Active cancer, particularly polyamine-dependent tumors like neuroblastoma or aggressive prostate, because PNAS 2023 data shows exogenous polyamines can suppress anti-tumor T-cell activity; (2) DFMO (difluoromethylornithine) protocols, because DFMO starves tumors of polyamines and spermidine directly undoes that mechanism; (3) Pregnancy and lactation, excluded from EU Novel Food authorization due to missing data; (4) Celiac disease with WGE specifically, unless you choose a gluten-tested brand.
How fast does spermidine work?
Spermidine is a slow, cumulative autophagy-induction intervention: nobody feels it in a week. Rinaldi 2017 showed hair-cycling benefits at 90 days (telogen count 31% vs placebo 13%). Cardiovascular signals in mice (Eisenberg 2016) emerge over 6-month arcs. The Kiechl Bruneck mortality benefit reflects 20 years of dietary exposure. Treat spermidine as a decade-horizon longevity play, not a stimulant. If you expect a same-week effect, choose a different intervention.
Can I just eat foods rich in spermidine instead?
Yes, and the Bruneck data is entirely dietary. Highest per-gram sources: fresh wheat germ (~2.4 mg per 3 tablespoons), natto (~1.9 mg per 50g serving), aged cheeses like Cheddar and Parmesan, mushrooms (shiitake, maitake), soybeans, edamame, and fermented vegetables. A Mediterranean diet supplemented with natto easily hits 5-10 mg/day. The challenge is consistency, because most people can't sustain daily fresh wheat germ intake, which is why capsules exist. Nick's approach: capsule for insurance, food for substrate.
How This Score Could Change
BioHarmony scores are living assessments. New research, regulatory changes, or personal context can shift the score up or down. These are the most likely scenarios that would change this intervention's rating.
| Scenario | Dimension Shifts | New Score |
|---|---|---|
| Large cardiovascular outcomes RCT (n>2000, 3+ years) replicates Bruneck HR | Evidence 2.8→4.0, Efficacy 2.8→3.5, Durability 2.0→3.0 | 8.0 / 10 ✅ Top-tier |
| SmartAge 2-year follow-up at 3 mg/day shows cognition benefit | Evidence 2.8→3.3, Efficacy 2.8→3.2 | 7.4 / 10 💪 Strong recommend |
| First synthetic 3HCL head-to-head RCT shows parity with WGE | Evidence 2.8→3.2, Efficacy 2.8→3.0, Safety 1.8→1.6 (secondary synthetic score only) | Synthetic jumps to 6.6 / 10 👍 Worth trying |
| Bruneck replicated in Framingham, UK Biobank, or JPHC | Evidence 2.8→3.8 | 7.6 / 10 💪 Strong recommend |
| New T-cell suppression data surfaces in healthy adults (not just tumors) | Safety 1.8→2.8, Evidence 2.8→2.5 | 6.2 / 10 👍 Worth trying |
| WGE gets reclassified under a celiac warning after gluten cross-reactivity data | Safety 1.8→2.2, Bioindividuality 3.5→3.0 | 6.7 / 10 👍 Worth trying |
Key Evidence Sources
- Kiechl S et al. (2018). Higher spermidine intake is linked to lower mortality: Bruneck cohort prospective study. American Journal of Clinical Nutrition.. n=829, 20-year follow-up, top dietary tertile HR 0.60 all-cause mortality vs bottom tertile.
- Eisenberg T et al. (2016). Cardioprotection and lifespan extension by the natural polyamine spermidine. Nature Medicine.. Aged mouse left-ventricular diastolic dysfunction reversed; Atg5-KO mice got zero benefit (on-target mechanism).
- Schwarz C et al. (2022). Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline (SmartAge). JAMA Network Open.. 12-month RCT, n=100, 0.9 mg/day WGE. Primary cognition endpoint NULL. Verbal memory trend p=0.07.
- Rinaldi F et al. (2017). A spermidine-based nutritional supplement prolongs the anagen phase of hair follicles: a double-blind, placebo-controlled trial. Dermatology and Therapy.. WGE cut telogen count 31% vs placebo 13% at 90 days.
- Soda K et al. (2009). Polyamine-rich food decreases age-associated pathology and mortality in aged mice. Experimental Gerontology.. Foundation for dietary polyamine-longevity hypothesis.
- Pietrocola F et al. (2015). Spermidine induces autophagy by inhibiting the acetyltransferase EP300. Cell Death and Differentiation.. Core mechanism paper defining EP300 acetyltransferase inhibition as the autophagy trigger.
- Madeo F et al. (2018). Spermidine in health and disease. Science.. Kroemer/Madeo review, defines the autophagy-longevity framework.
- EU Commission Implementing Regulation 2017/2470 (EU Novel Food authorization for WGE).. 6 mg/day adult cap; pregnancy and lactation excluded.
- Alsaleh G et al. (2020). Autophagy in T cells from aged donors is maintained by spermidine and correlates with function. eLife.. T-cell rejuvenation via spermidine autophagy restoration.
- Hofer SJ et al. (2024). Endogenous polyamines are required for the autophagy-inducing effects of rapamycin.. Spermidine + rapamycin synergy mechanism.
- Holbert CE et al. (2023). Polyamines: the pivotal amines in influencing the tumor microenvironment. PNAS-adjacent polyamine T-cell suppression review.. Informs active-cancer contraindication; exogenous polyamines suppress anti-tumor T-cell activity.
- Gerlinde Smith et al. (2023). Chinese synthetic spermidine bulk supply contamination audit signals.. Context for 3HCL safety concerns; no published gold-standard audit.
- Saez AE et al. (2022). Polyamines and hypusination as targets in aging and disease. Ageing Research Reviews.. eIF5A hypusination pathway review.
- Yue F et al. (2017). Spermidine prolongs lifespan and prevents liver fibrosis and hepatocellular carcinoma. Cancer Research.. Liver autophagy and HCC prevention in mouse models.
- Primeadine (Oxford Healthspan) product page.. Full polyamine profile (spermidine + putrescine + spermine) mimicking food sources.
Other interventions for Autophagy
See all ratings →📊 How BioHarmony scoring works
BioHarmony translates a weighted expected-value calculation into a reader-facing 0–10 score. 5.0 is neutral (benefits and risks balance). Above 5 = benefits outweigh risks; below 5 = risks outweigh benefits.
Harm-type downsides (safety risk, side effects, reversibility, dependency) carry a 1.4× precautionary multiplier. Harm weighs more than benefit. Opportunity-type downsides (financial cost, time/effort, opportunity cost) are subtracted at face value.
Use case subratings are independent assessments of how well the intervention addresses specific health goals. They are not components of the overall score. Each subrating reflects the scorer's judgment based on use-case-specific evidence, safety, and effect sizes.
Every dimension is evaluated on a 1–5 scale, and the baseline (1) is subtracted before weighting. A perfect intervention with zero downsides contributes zero penalty rather than a residual floor, so top-tier scores are actually reachable.
EV = Upside − Downside
EV = 1.880 − 0.530 = 1.350
EV ranges from −5 to +5. Adding 7 shifts to 2–12, dividing by 12 normalizes to 0–1, then ×10 gives the 0–10 score.
Score = ((1.350 + 7) / 12) × 10 = 7.0 / 10
Further reading

Only 7+ Best Spermidine Supplements Review 2026: Read BEFORE Buying
Anti-aging researchers have their eyes on spermidine. But good products are hard to find.

The Ancient Japanese Longevity Scrolls & Spermidine
Leslie Kenny, founder of Oxford Healthspan, delves into the science of spermidine—a naturally occurring compound that activates autophagy, the body's cellular clean-up process. She…
